MAX Bater papo
Cronograma de promoção Recursion Pharmaceuticals, Inc.
Agenda avançada
Gráfico simples
Parâmetros básicos
IPO date
2021-04-16
ISIN
US75629V1044
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
Nota
Subestimação
| Nome | Significado | Nota |
| P/S | 31.5 | 1 |
| P/BV | 1.79 | 8 |
| P/E | 0 | 0 |
Eficiência
| Nome | Significado | Nota |
| ROA | -44.11 | 0 |
| ROE | -61.89 | 0 |
| ROIC | -127.47 | 0 |
Dividendos
| Nome | Significado | Nota |
| Rendimento de dividendos | 0 | 0 |
| DSI | 0 | 0 |
| Crescimento médio dos dividendos | 0 | 0 |
Obrigação
| Nome | Significado | Nota |
| Debt/EBITDA | -0.2542 | 10 |
| Debt/Ratio | 0.0749 | 10 |
| Debt/Equity | 0.3999 | 10 |
Impulso de crescimento
| Nome | Significado | Nota |
| Receita, % | 1370.98 | 10 |
| Ebitda, % | 425.49 | 10 |
| EPS, % | 119.6 | 10 |
paper.price.prices
| Preço | Common.min. | Common.max. | Mudar | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 5.17 $ | 0 $ | 0 $ | -1.45 % | 0 % | 0 % |
| common.calendar.number_days.7d | 4.57 $ | 0 $ | 0 $ | +11.49 % | 0 % | 0 % |
| common.calendar.number_days.30d | 4.15 $ | 0 $ | 0 $ | +22.92 % | 0 % | 0 % |
| common.calendar.number_days.90d | 4.65 $ | 4.08 $ | 5.7 $ | +9.57 % | 0 % | 0 % |
| common.calendar.number_days.180d | 7.61 $ | 3.97 $ | 10.87 $ | -33.05 % | 0 % | 0 % |
| common.calendar.number_days.1y | 7.61 $ | 3.97 $ | 10.87 $ | -33.05 % | 0 % | 0 % |
| common.calendar.number_days.3y | 10.99 $ | 3.97 $ | 15.86 $ | -53.64 % | 0 % | 0 % |
| common.calendar.number_days.5y | 3.97 $ | 3.97 $ | 41.33 $ | +128.34 % | 0 % | 0 % |
| common.calendar.number_days.10y | 3.97 $ | 3.97 $ | 41.33 $ | +128.34 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 6.42 $ | 3.97 $ | 10.87 $ | -20.64 % | 0 % | 0 % |
Negociação de informações privilegiadas
Principais proprietários
Contido em ETF
ETF | Compartilhar, % | Rentabilidade para o ano, % | Comissão, % |
| Future Tech ETF | 0.18148 | 479.5 | 0.35 |
| Principal Healthcare Innovators ETF | 0.18148 | -3.92 | 0.35 |
| iShares Morningstar Small-Cap Growth ETF | 0.06084 | 570.49 | 0.06 |
| iShares Morningstar Small-Cap ETF | 0.03054 | 301.34 | 0.25 |
| 0,11 | 336,85 | 0,25 |
|---|
Empresas semelhantes
P/E & P/BV
Gestão da empresa
| Supervisor | Cargo | Pagamento | Ano de nascimento |
| Ms. Tina Marriott Larson | COO & President | 612.69k | 1975 (50 anos) |
| Dr. Blake C. Borgeson Ph.D. | Co-Founder & Director | 40k | 1982 (43 ano) |
| Dr. Michael Secora Ph.D. | Chief Financial Officer | 524.19k | 1983 (42 ano) |
| Mr. Benjamin Mabey M.S. | Chief Technology Officer | N/A | 1983 (42 ano) |
| Dr. Christopher C. Gibson Ph.D. | Co-Founder, CEO & Director | 695.18k | 1983 (42 ano) |
| Kevin Leggat | Vice President of Finance & Accounting | N/A | |
| Mr. Jared Allenbach | Senior Director of Investor Relations | N/A | |
| Mr. Ryan Kelly | Chief Communications Officer | N/A | |
| Mr. Nathan Hatfield | Chief Legal Officer & General Counsel | N/A | |
| Dr. David J. Mauro M.D., Ph.D. | Chief Medical Officer | 1965 (60 anos) |
Informações da empresa
Endereço: United States, Salt Lake City, 41 South Rio Grande Street - Abrir no google maps, Abrir mapas yandex
Site: http://www.recursion.com
Site: http://www.recursion.com
Sobre a empresa Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. работает как биотехнологическая компания на клинической стадии, расшифровывающая биологию путем интеграции технологических инноваций в области биологии, химии, автоматизации, науки о данных и инженерии для индустриализации открытия лекарств. В нем есть четыре кандидата на клинические препараты, предназначенные для лечения редких моногенных заболеваний; и 33 дополнительных программы на разных стадиях доклинической разработки. Recursion Pharmaceuticals, Inc. имеет стратегические соглашения с Bayer; Государственный инновационный фонд Огайо; Chromaderm, Inc .; и Takeda Pharmaceutical Company Limited. Компания была основана в 2013 году и базируется в Солт-Лейк-Сити, штат Юта.
